Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : Home on the range where the buffalo roam -- Ignore unavailable to you. Want to Upgrade?

To: Boplicity who wrote (10845)	2/26/2001 10:17:09 AM
From: Boplicity	Read Replies (1) \| Respond to of 13572

10:05 ET Genomics Stocks : Human Genome (HGSI +5 1/4) news (see 09:35 comment) sparks early run in stock, and attracts investors/traders to sector. Much of early gains appear to have been fueled by short-covering. Beginning to see sector ease as overall market gives ground. Movers of note include MLNM +4, CRA +3 5/8, MYGN +2 1/4. I'm going to watch HGSI closely, might by the dip after the bounce off the double bottom. Greg

To: Boplicity who wrote (10845)	2/26/2001 4:51:51 PM
From: mishedlo	Read Replies (3) \| Respond to of 13572

or the market is being supported by rate reduction anticipation still. You know the answer. Most of the bears on the bear threads covered last Thursday. I covered Friday. Waiting for a chance to sell the news. I think what Angell did is criminal. 1) He can not possibly know what the Fed is going to do 2) If he does it is insider knowlege 3) He should be put under SEC investigation. What he did was far far worse that what that 15 year old kid did IMHO. Blatant market manipulation to protect his clients if you ask me. M